IL-2-based cancer vaccines: Failure of mouse melanoma cells producing high amounts of IL-2 to induce protective immunity is not due to tumor-specific tolerance.

被引：0
|
作者：
Schneeberger, A
Sabol, M
Kutil, R
Schmidt, W
Kolesaric, A
Stingl, G
机构：
[1] UNIV VIENNA,SCH MED,DEPT DERMATOL,DIAID,VIENNA,AUSTRIA
[2] IMP,VIENNA,AUSTRIA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 1997年 / 109卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：407 / 407
页数：1
相关论文
共 9 条
  • [1] Cytokine based cancer vaccines: Failure of murine melanoma vaccines producing high amounts of IL-2 to induce protective immunity is npt due to tumor-specific tolerance.
    Schneeberger, A
    Kutil, R
    Schmidt, W
    Kolesaric, A
    Strommer, S
    Stingl, G
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (04) : 347 - 347
  • [2] Allergen alters IL-2/αIL-2-based Treg expansion but not tolerance induction in an allergen-specific mouse model
    Koehler, Cordula
    Smole, Ursula
    Kratzer, Bernhard
    Trapin, Doris
    Schmetterer, Klaus G.
    Pickl, Winfried F.
    ALLERGY, 2020, 75 (07) : 1618 - 1629
  • [3] IL-12 acid IL-2 potentiate the in vitro tumor-specific activity of peripheral blood cells from cervical cancer patients
    Verma, V
    Sharma, V
    Shrivastava, SK
    Nadkarni, JJ
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2000, 19 (03) : 367 - 374
  • [4] Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer Immunotherapy
    Furusawa, Aki
    Reiser, John
    Sadashivaiah, Kavitha
    Simpson, Haley
    Banerjee, Arnob
    JOURNAL OF IMMUNOTHERAPY, 2018, 41 (02) : 53 - 63
  • [5] Efficacy of cancer gene therapy in aging: adenocarcinoma cells engineered to release IL-2 are rejected but do not induce tumor specific immune memory in old mice
    Provinciali, M
    Argentati, K
    Tibaldi, A
    GENE THERAPY, 2000, 7 (07) : 624 - 632
  • [6] Efficacy of cancer gene therapy in aging: adenocarcinoma cells engineered to release IL-2 are rejected but do not induce tumor specific immune memory in old mice
    M Provinciali
    K Argentati
    A Tibaldi
    Gene Therapy, 2000, 7 : 624 - 632
  • [7] Tumor cell lysate-based vaccines augmented with low dose IL-2 can induce potentially beneficial specific immune responses in plasma cell dyscrasias.
    Lim, SH
    Wen, YJ
    Yi, Q
    Ling, M
    Barlogie, B
    BLOOD, 1999, 94 (10) : 312B - 312B
  • [8] Generation of Potent Tumor-Specific CTLs from High-Dose IL-2 Activated naive CD8 T Cells with Overcoming the Tumor-Derived Immune Suppression
    Nguyen, Hong-Hanh
    Kim, Dong-hwan
    Lee, Hyun-Ju
    Jung, Sung-Hoon
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    Yang, Deok-Hwan
    BLOOD, 2014, 124 (21)
  • [9] Some but not all memory CD8 T cell subsets produce both IFN-g and IL-2: Comparison of viral- and tumor-specific T cells in cancer patients and healthy donors
    Bercovici, N
    Mallard, E
    Vernel-Pauillac, F
    Massicard, S
    Lehmann, F
    Velu, T
    Ferries, E
    Leccia, MT
    Taylor, R
    Salcedo, M
    Abastado, JP
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S39 - S39
1